Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 4.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.1 | 2.2 |
NAV | ₹23.56 | ₹102.34 |
Fund Started | 29 Jul 2022 | 25 Mar 1997 |
Fund Size | ₹834.33 Cr | ₹1072.74 Cr |
Exit Load | Exit Load: 1%- If redeemed on or before 15 days from the date of allotment. | Exit load of 1%, if redeemed within 30 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 24.61% | 28.35% |
3 Year | - | 26.27% |
5 Year | - | 25.03% |
1 Year
3 Year
5 Year
Equity | 99.69% | 99.31% |
Cash | 0.15% | 0.69% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
State Bank of India | 11.44% |
Hindalco Industries Ltd. | 10.62% |
Grasim Industries Ltd. | 10.19% |
Oil And Natural Gas Corporation Ltd. | 9.43% |
Bharat Petroleum Corporation Ltd. | 6.10% |
Indian Oil Corporation Ltd. | 6.05% |
Jindal Steel & Power Ltd. | 4.95% |
GAIL (India) Ltd. | 4.23% |
UPL Ltd. | 3.93% |
Hindustan Petroleum Corporation Ltd. | 3.79% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 7.21% |
Infosys Ltd. | 4.57% |
ICICI Bank Ltd. | 4.12% |
Dr. Reddy's Laboratories Ltd. | 3.14% |
State Bank of India | 2.74% |
NTPC Ltd. | 2.64% |
REC Ltd. | 2.49% |
Tech Mahindra Ltd. | 2.23% |
Amber Enterprises India Ltd. | 2.16% |
Suven Pharmaceuticals Ltd. | 2.07% |
Name | Swapnil P Mayekar | Satish Ramanathan |
Start Date | 14 Jul 2022 | 01 Oct 2024 |
Name
Start Date
Description | The scheme seeks to provide returns that, before expenses, correspond to the total returns of the securities as represented by the S&P BSE Enhanced Value Index, subject to tracking error. | The scheme aims to provide long term capital growth by investing primarily in a well-diversified portfolio of undervalued securities. |
Launch Date | 29 Jul 2022 | 25 Mar 1997 |
Description
Launch Date